Welcome to our dedicated page for Nova SEC filings (Ticker: NVMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nova Ltd. filings document its foreign private issuer reporting for a semiconductor metrology and process control company. Form 6-K current reports incorporate press releases on financial results, scheduled earnings releases, investor conference participation, product adoption for Nova Metrion®, and other operating updates. The Form 20-F annual report includes audited consolidated financial statements and establishes the company's reporting framework under Form 20-F rather than Form 40-F.
The filing record also identifies Nova's Nasdaq ticker NVMI and TASE trading status. Current reports preserve formal notices for annual-report availability, scheduled conference calls and public communications made under Exchange Act Rule 13a-16 or 15d-16.
Sagiv Sarit reported acquisition or exercise transactions in this Form 4 filing.
NOVA LTD. director Sagiv Sarit received an equity award of 334 ordinary shares on June 18, 2026, recorded at no cash cost per share. Following this grant, Sarit directly holds 2,771 ordinary shares, combining vested shares and multiple restricted share unit (RSU) awards.
The position includes RSUs that vest in equal annual installments through 2028, with 827 RSUs fully vesting on June 18, 2026 and additional blocks of 454, 426, 546 and 334 RSUs scheduled to vest in future years, subject to continued service.
COHEN AVI reported acquisition or exercise transactions in this Form 4 filing.
NOVA LTD. director Avi Cohen reported receiving an equity grant of 334 ordinary-share RSUs on June 18, 2026. The award was granted at no cash cost to him and increases his direct holdings to 8,702 ordinary shares and RSUs combined.
The new 334 RSUs are scheduled to vest in full on June 18, 2027, if he continues providing service to the company. Existing RSU awards are structured to vest in equal annual installments through 2026, 2027 and 2028, aligning his compensation with ongoing service over several years.
Simon Zehava reported acquisition or exercise transactions in this Form 4 filing.
NOVA LTD. director Zehava Simon received a routine equity award. On June 18, 2026, she was granted 334 ordinary shares at a price of $0.00 per share as a compensation-related award, not an open-market purchase.
After this grant, her direct holdings total 2,771 ordinary shares. This includes 184 shares plus multiple tranches of restricted share units (RSUs) that vest annually through 2028, with 827 RSUs fully vesting on June 18, 2026 and the new 334 RSUs scheduled to vest in full on June 18, 2027, subject to continued service.
Cohen Raanan reported acquisition or exercise transactions in this Form 4 filing.
NOVA LTD. director Raanan Cohen received an equity grant of 334 ordinary shares on June 18, 2026 at no cost as a share-based award. After this grant, his directly held position reported in the filing is 6,048 ordinary shares, including previously granted restricted share units that vest over several years.
Garty Yaniv reported acquisition or exercise transactions in this Form 4 filing.
NOVA LTD. director Yaniv Garty received a grant of 334 ordinary shares on June 18, 2026 as a share award, at no cash price. After this grant, he reports beneficial ownership of 2,372 ordinary shares, including multiple blocks of restricted share units that vest annually through 2028.
NOVA LTD. director Eitan Oppenhaim received an equity award of 1,043 ordinary shares on June 18, 2026, recorded at no cash price as a grant. After this award, he directly holds 7,711 ordinary shares, including both currently held shares and restricted share units that convert into shares as they vest through 2028.
Nova Ltd. submitted a notice under Form 144 reporting proposed and recent transactions in ordinary shares of the issuer (symbol NVMI). The excerpt lists 366 shares issued upon vesting of RSUs on 06/20/2025 and two reported sales: 55 shares on 04/02/2026 and 426 shares on 05/18/2026.
Nova Ltd. reported that it held its annual general meeting of shareholders on June 18, 2026 at its offices in Israel. Shareholders voted on three proposals that were previously described in the company’s proxy statement, and all three proposals were approved by the required shareholder vote.
The company also stated that this report is incorporated by reference into its existing Form S-8 registration statement related to equity compensation plans, linking the meeting’s approved matters into that registration framework.
Waisman Gabriel reported acquisition or exercise transactions in this Form 4 filing.
NOVA LTD. CEO and President Gabriel Waisman received 3,000 ordinary shares as a stock-based award. The shares were issued at no cash cost upon settlement and vesting of a performance stock unit granted under the company’s 2017 Share Incentive Plan after achievement of a performance condition on June 1, 2026.
Following this award, Waisman directly holds 24,624 ordinary shares, a figure that includes previously held shares and multiple tranches of restricted share units scheduled to vest annually through 2029, each RSU delivering one ordinary share upon vesting and settlement.
NOVA LTD. director Eitan Oppenhaim reported an open-market sale of 1,504 ordinary shares on May 26, 2026 at an average price of $519.48 per share. Following the transaction, he directly holds 6,668 ordinary shares.
Footnotes state these holdings include 646 ordinary shares and several blocks of restricted share units (RSUs): 1,504 RSUs vesting annually through 2027, 1,932 RSUs vesting annually through 2028, and 2,586 RSUs scheduled to vest on June 18, 2026, each RSU convertible into one ordinary share upon vesting and settlement.